‘Unacceptable safety risk’: Major European country bans puberty blockers for minors

The United Kingdom (UK) indefinitely banned the use of puberty-blocking drugs for minors Wednesday after recommendations from experts that warned of an “unacceptable safety risk.”

The ban affects the sale and supply of the drugs to all citizens under 18 following an independent review by the Commission on Human Medicines, according to a press release from the British government. The ban will be reviewed in 2027.

“The Commission on Human Medicines (CHM) has provided independent expert advice that there is currently an unacceptable safety risk in the continued prescription of puberty blockers to children,” the statement reads. “It recommends indefinite restrictions while work is done to ensure the safety of children and young people.”

The UK previously halted the prescription of puberty blockers for children in March after it found “insufficient evidence to show they were safe.”

Other “gender services” for children will continue in the nation, the release stated. Patients who have already been prescribed the drugs will still have access to them.

“We are working with NHS England to open new gender identity services, so people can access holistic health and wellbeing support they need,” Health and Social Care Secretary Wes Streeting said in a statement. “We are setting up a clinical trial into the use of puberty blockers next year, to establish a clear evidence base for the use of this medicine.”

The UK’s only youth gender clinic, Tavistock Centre, was shut down in 2022 over concerns it was rushing children through sex-change procedures without proper evidence, and an investigation revealed it was “not safe” for kids.

A United States study failed to prove any efficacy in improving children’s mental health by prescribing puberty blockers, though the full results of the study have yet to be released reportedly because the researcher did not want the findings to be used by opponents of sex-change procedures for children.

The Department of Health and Social Care did not immediately respond to the Daily Caller News Foundation’s request for comment.

All republished articles must include our logo, our reporter’s byline, and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact licensing@dailycallernewsfoundation.org.

DONATE TO BIZPAC REVIEW

Please help us! If you are fed up with letting radical big tech execs, phony fact-checkers, tyrannical liberals and a lying mainstream media have unprecedented power over your news please consider making a donation to BPR to help us fight them. Now is the time. Truth has never been more critical!